Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results

Go back to Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
Beam Inc. (NASDAQ: BEAM) Delayed: 25.67 --0 (-0%)
Previous Close $25.67    52 Week High $83.60 
Open $25.67    52 Week Low $82.96 
Day High $25.67    P/E 11.46 
Day Low $25.67    EPS $2.24 
Volume 4,535